Searching for new drugs is guided by their specificity and potency. The met
hodology, including the statistical approaches, orients itself to do exactl
y that. More potent drugs also have more side effects, a technology trap th
at requires a radical re-examination regarding how to go about drug discove
ry. It is relevant in an era when quality of life is emerging as more impor
tant than the ill-kept promise of dramatic therapies. Interestingly, the pr
oblem statement can be formalized and a strategy can be identified that req
uires new methodological grounds to be covered within the scope of allopath
y.